Event-Test-100

May 15-30, 2019 | India

This is description. A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies.A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies.A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies.A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies.A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies.A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies. This is description. A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies.A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies.A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies.A revamped programme for 2019 ensures you gain a comprehensive look at immuno-oncology drug development from early discovery through to the clinic, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors, and oncolytic viral therapies.A revamped programme for 2019 ensures you gain a comprehensive look at.

Spotlight

Satya Nadella, CEO of Microsoft, discusses the importance of collaboration in the workplace. He shares insights on how many minds are better than one, and that being empathetic to your coworkers makes everyone perform better. Fast Company is the world's leading progressive business media brand,


OTHER PAST CONFERENCES

Autonomous Driving AI Test Challenge

August 23-26, 2021 | USA

It will take place from 23rd August to 26th August. This platform provides a global competition opportunity for international student teams and professional teams to develop diverse simulation testing techniques and approaches in test scenario generation and automation. In this challenge, LGSVL simulator will be used to support simulation testing and execution. LGSVL simulator is a Unity-based autonomous vehicle simulator developed by LG Electronics America R&D Center. LGSVL simulator is fully integrated with the open-source platforms Baidu Apollo and Autoware. In this challenge, teams will use LGSVL integrated with Baidu Apollo to generate and evaluate test cases. This evaluation criteria listed below provides detailed assessment rubrics for AV test simulation scenario generation and script generation from different teams.

AI 4 2021

August 17-19, 2021 | USA

Ai4 is the organizer behind industry’s most impactful AI events. By gathering leaders of enterprise from across industry, government organizations, disruptive startups, investors, research labs, academia, associations, open source projects, media and analysts, we are creating the largest and most influential arena for idea-sharing, AI-related commerce, and technological progress.Our mission is to help provide a common framework for what AI means to both enterprise and the future of our globe as we transition into a new era of responsible human-machine collaboration.

International Conference On Soft Computing, Artificial Intelligence And Applications

August 16-17, 2021 | USA

International Conference On Soft Computing, Artificial Intelligence And Applications aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results on all aspects of Soft Computing, Artificial Intelligence and Applications. It also provides a premier interdisciplinary platform for researchers, practitioners, and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Soft Computing, Artificial Intelligence, and Applications.

International Conference on Frontiers of Artificial Intelligence and Machine

August 13-15, 2021 | Sweden

International Conference on Frontiers of Artificial Intelligence and Machine welcomes researchers, engineers, scientists, and industry professionals to an open forum where advances in the field of artificial intelligence and machine learning can be shared and examined. The conference is an ideal platform for keeping up with advances and changes to a consistently morphing field. Leading researchers and industry experts from around the globe will be presenting the latest studies through papers and oral presentations.